Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants
Racemic ±3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to others. These acute subjective effects of MDMA may be helpful to assist psychotherapy and MDMA has been investigated in phase 3 trials as a possible treatment in post-traumatic stress disorder.
- Status
- completed
- Phase
- Phase 1
- Institution
- University Hospital, Basel, Switzerland
- Principal investigator
- Matthias E Liechti, Prof. Dr. MD
- Start date
- 2025-07-29
- End date
- 2026-05-12
- Registry ID
- NCT06905652
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.